A Phase 1 trial testing RAG-17, a potential ALS therapy for people carrying SOD1 mutations, has dosed its first participant.

The creatinine-to-cystatin C ratio may indicate the risk of developing amyotrophic lateral sclerosis, a large-scale database ...

Despite the lower ALS risk, heart and metabolism problems are tied to faster disease progression and worse survival in the ...

This content is sponsored by Mitsubishi Tanabe Pharma America, Inc. (MTPA) and is intended for US audiences only. Any other ...

Throughout 2024, ALS News Today brought our readers daily coverage of the latest in scientific breakthroughs, treatment advances, and clinical trial updates related to amyotrophic lateral sclerosis ...

Columnist Kristin Neva is applying something she learned about finding moments to appreciate during winter to life with ALS.

I named my column “Living Well with ALS” for many reasons. The most important one was that each word in the title had a deep meaning for me. Before I was diagnosed with ALS in 2010, my life was ...